North America Cardiac Output Monitoring Devices Market, By Product Type (Invasive, Minimally Invasive, Non-Invasive), By End User (Hospital, Ambulatory Care, Others) – Forecast to 2020
The North American cardiac output monitoring devices market is estimated to grow at a CAGR of 7.6% from 2015 to 2020. The market holds high potential for growth in future, owing to a number of factors, which include the rising incidences of cardiovascular diseases, favorable government initiatives, and increasing contribution of independent organizations towards the growth of this market. Moreover, various technological advancements taking place in cardiac output monitoring devices are also driving the growth of this market. The demand for high-end, non-invasive devices is on the rise and is moving in tandem with the increasing need for highly sophisticated technologies, which can offer reliable and quick results. However, factors such as unstable reimbursement policies and low level of accuracy with invasive cardiac output monitoring devices are expected to restrain the growth of this market during the forecast period.
In this report, the North American cardiac output monitoring devices market has been broadly classified on the basis of product type into invasive, minimally invasive, and non-invasive cardiac output monitoring devices. By end user, the market has been classified into hospitals and ambulatory care. Geographically, the market has been further sub segmented into the U.S., Canada, and Mexico.
The U.S. held the largest share in the North American cardiac output monitoring devices market in 2014, and accounted for a market share of 89.4%, followed by Canada. The growth of the cardiac output monitoring devices market in the U.S. is likely to be driven by the prevalence of cardiovascular diseases, owing to increase in the number of people suffering from obesity in the country. Moreover, the increase in the number of corporate agreements between the leading players operating in the North American cardiac output monitoring devices market is also expected to fuel growth of this market between 2015 and 2020.
The report has profiled the leading players in this market along with the recent developments, such as new product launches, partnerships, agreements, collaborations, and joint ventures undertaken by them during the past three years. It also provides information on the strategies adopted by these market players to sustain and strengthen their position in the North American cardiac output monitoring devices market. Some of the key players operating in this market are Edwards Lifesciences Corporation (U.S.), PULSION Medical Systems SE (Germany), Deltex Medical Ltd. (U.K.), LiDCO Group plc (U.K.), and ICU Medical, Inc. (U.S.), among others.
Reasons to Buy the Report:
From the insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends and PEST analysis), market share analysis of the top players, supply chain analysis, and company profiles. These insights together comprise and discuss basic views on the competitive landscape, usage patterns, emerging,- and high-growth segments of the North American cardiac output monitoring devices market, high-growth countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help them in garnering an increased market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
In this report, the North American cardiac output monitoring devices market has been broadly classified on the basis of product type into invasive, minimally invasive, and non-invasive cardiac output monitoring devices. By end user, the market has been classified into hospitals and ambulatory care. Geographically, the market has been further sub segmented into the U.S., Canada, and Mexico.
The U.S. held the largest share in the North American cardiac output monitoring devices market in 2014, and accounted for a market share of 89.4%, followed by Canada. The growth of the cardiac output monitoring devices market in the U.S. is likely to be driven by the prevalence of cardiovascular diseases, owing to increase in the number of people suffering from obesity in the country. Moreover, the increase in the number of corporate agreements between the leading players operating in the North American cardiac output monitoring devices market is also expected to fuel growth of this market between 2015 and 2020.
The report has profiled the leading players in this market along with the recent developments, such as new product launches, partnerships, agreements, collaborations, and joint ventures undertaken by them during the past three years. It also provides information on the strategies adopted by these market players to sustain and strengthen their position in the North American cardiac output monitoring devices market. Some of the key players operating in this market are Edwards Lifesciences Corporation (U.S.), PULSION Medical Systems SE (Germany), Deltex Medical Ltd. (U.K.), LiDCO Group plc (U.K.), and ICU Medical, Inc. (U.S.), among others.
Reasons to Buy the Report:
From the insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends and PEST analysis), market share analysis of the top players, supply chain analysis, and company profiles. These insights together comprise and discuss basic views on the competitive landscape, usage patterns, emerging,- and high-growth segments of the North American cardiac output monitoring devices market, high-growth countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help them in garnering an increased market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
- Product Analysis and Development: Detailed insights on the upcoming technologies, research and development activities, and new product launches in the North American cardiac output monitoring devices market. Usage pattern/ penetration rate (in-depth trend analysis) of products (segment wise) and purchasing data. Comprehensive coverage of product approvals, patent analysis, pipeline products, and product recalls
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for cardiac output monitoring devices across geographies, new distribution channels, new clientele base, and different pricing policies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investment decisions in the North American cardiac output monitoring devices market. Detailed description regarding the related and unrelated diversification pertaining to this market
- Competitive Assessment: In-depth assessment of market shares and company share analysis of the key players forecast till 2020. Business strategies and manufacturing capabilities of the leading players to enhance the bottom line of the companies in the North American cardiac output monitoring devices market
- Product/ Brand Perception Analysis: Comprehensive study of customers perception and behavior through our inbuilt social connect tool (digital marketing language), checking virality and tonality of blogs
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET SEGMENTATION & COVERAGE
1.3 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 KEY DATA FROM SECONDARY SOURCES
2.2 KEY DATA FROM PRIMARY SOURCES
2.3 INTEGRATED ECOSYSTEM OF CARDIAC OUTPUT MONITORING DEVICES MARKET
2.4 ARRIVING AT THE CARDIAC OUTPUT MONITORING DEVICES MARKET SIZE
2.5 TOP-DOWN APPROACH
2.5.1 BOTTOM-UP APPROACH
2.5.2 MACROINDICATOR-BASED APPROACH
2.6 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DRIVERS AND INHIBITORS
4.3 PORTER’S FIVE FORCES ANALYSIS
4.3.1 THREAT FROM NEW ENTRANTS: MODERATE
4.3.2 THREAT FROM SUBSTITUTES: MODERATE TO HIGH
4.3.3 BARGAINING POWER OF SUPPLIERS: LOW
4.3.4 BARGAINING POWER OF BUYERS: MODERATE TO HIGH
4.3.5 INTENSITY OF COMPETITIVE RIVALRY: MODERATE
5 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICES MARKET, BY TECHNOLOGY
5.1 INTRODUCTION
5.2 THERMODILUTION
5.2.1 THERMODILUTION
5.3 TRANSPULMONARY THERMODILUTION (TPTD)
5.4 PULSE PRESSURE ANALYSIS
5.4.1 PULSE POWER ANALYSIS
5.4.1.1 LiDCO System
5.4.2 PULSE CONTOUR ANALYSIS TECHNIQUES
5.4.2.1 ccNexfin
5.4.2.2 PiCCO System
5.4.2.3 FloTrac System
5.4.3 PRESSURE RECORDING ANALYTICAL METHOD (PRAM) TECHNIQUE
5.5 DOPPLER METHOD
5.5.1 ESOPHAGEAL DOPPLER
5.5.2 ULTRASOUND TECHNIQUES
5.6 BIOIMPEDANCE & BIOREACTANCE
5.7 OTHERS
5.7.1 TRANSESOPHAGEAL ECHOCARDIOGRAPHY (TEE)
5.7.2 PRESSURE WAVE TRANSIT TIME (PWTT)
5.7.3 CONTINUOUS NON-INVASIVE ARTERIAL PRESSURE (CNAP)
5.8 TECHNOLOGY SNAPSHOT
6 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICES MARKET, BY TYPE
6.1 INTRODUCTION
6.2 INVASIVE CARDIAC OUTPUT MONITORING
6.3 NON-INVASIVE CARDIAC OUTPUT MONITORING
6.4 MINIMALLY INVASIVE CARDIAC OUTPUT MONITORING
7 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICES MARKET, BY END-USER
7.1 HOSPITALS
7.1.1 CRITICAL CARE
7.1.2 PERI-OPERATIVE
7.2 AMBULATORY SURGICAL CENTERS
7.3 OTHERS
8 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICES MARKET, BY COUNTRY
8.1 INTRODUCTION
8.2 U.S.: CARDIAC OUTPUT MONITORING DEVICES MARKET
8.3 CANADA: CARDIAC OUTPUT MONITORING DEVICES MARKET
8.4 MEXICO: CARDIAC OUTPUT MONITORING DEVICES MARKET, BY TYPE
9 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICES MARKET, COMPETITIVE LANDSCAPE
9.1 INTRODUCTION
9.2 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICES MARKET: COMPANY SHARE ANALYSIS
9.3 AGREEMENT & ALLIANCE
9.4 PARTNERSHIP
9.5 COLLABORATION
9.6 EXPANSION
9.7 ACQUISITION
9.8 NEW PRODUCT LAUNCH
9.9 OTHERS
10 NON-INVASIVE AND MINIMALLY INVASIVE CARDIAC OUTPUT MONITORING, BY COMPANY
(Overview, Financials, Products & Services, Strategy, and Developments)*
10.1 CHEETAH MEDICAL
10.2 CNSYSTEM MEDIZINTECHNIK AG
10.3 DELTEX MEDICAL GROUP
10.4 EDWARDS LIFESCIENCES
10.5 FINAPRES MEDICAL SYSTEMS B.V.
10.6 ICU MEDICAL
10.7 LIDCO GROUP PLC
10.8 NIHON KOHDEN CORPORATION
10.9 PHILIPS HEALTHCARE (A SUBSIDIARY OF ROYAL PHILIPS ELECTRONICS)
10.10 PULSION MEDICAL SYSTEMS SE
10.11 TENSYS MEDICAL, INC.
10.12 USCOM LTD
10.13 BIOSENSORS INTERNATIONAL
10.14 INTRA SPECIAL CATHETERS GMBH
10.15 B. BRAUN MELSUNGEN AG
10.16 ARGON MEDICAL DEVICES, INC.
*Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company
11 APPENDIX
11.1 CUSTOMIZATION OPTIONS
11.1.1 PRODUCT ANALYSIS
11.2 RELATED REPORTS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET SEGMENTATION & COVERAGE
1.3 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 KEY DATA FROM SECONDARY SOURCES
2.2 KEY DATA FROM PRIMARY SOURCES
2.3 INTEGRATED ECOSYSTEM OF CARDIAC OUTPUT MONITORING DEVICES MARKET
2.4 ARRIVING AT THE CARDIAC OUTPUT MONITORING DEVICES MARKET SIZE
2.5 TOP-DOWN APPROACH
2.5.1 BOTTOM-UP APPROACH
2.5.2 MACROINDICATOR-BASED APPROACH
2.6 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DRIVERS AND INHIBITORS
4.3 PORTER’S FIVE FORCES ANALYSIS
4.3.1 THREAT FROM NEW ENTRANTS: MODERATE
4.3.2 THREAT FROM SUBSTITUTES: MODERATE TO HIGH
4.3.3 BARGAINING POWER OF SUPPLIERS: LOW
4.3.4 BARGAINING POWER OF BUYERS: MODERATE TO HIGH
4.3.5 INTENSITY OF COMPETITIVE RIVALRY: MODERATE
5 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICES MARKET, BY TECHNOLOGY
5.1 INTRODUCTION
5.2 THERMODILUTION
5.2.1 THERMODILUTION
5.3 TRANSPULMONARY THERMODILUTION (TPTD)
5.4 PULSE PRESSURE ANALYSIS
5.4.1 PULSE POWER ANALYSIS
5.4.1.1 LiDCO System
5.4.2 PULSE CONTOUR ANALYSIS TECHNIQUES
5.4.2.1 ccNexfin
5.4.2.2 PiCCO System
5.4.2.3 FloTrac System
5.4.3 PRESSURE RECORDING ANALYTICAL METHOD (PRAM) TECHNIQUE
5.5 DOPPLER METHOD
5.5.1 ESOPHAGEAL DOPPLER
5.5.2 ULTRASOUND TECHNIQUES
5.6 BIOIMPEDANCE & BIOREACTANCE
5.7 OTHERS
5.7.1 TRANSESOPHAGEAL ECHOCARDIOGRAPHY (TEE)
5.7.2 PRESSURE WAVE TRANSIT TIME (PWTT)
5.7.3 CONTINUOUS NON-INVASIVE ARTERIAL PRESSURE (CNAP)
5.8 TECHNOLOGY SNAPSHOT
6 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICES MARKET, BY TYPE
6.1 INTRODUCTION
6.2 INVASIVE CARDIAC OUTPUT MONITORING
6.3 NON-INVASIVE CARDIAC OUTPUT MONITORING
6.4 MINIMALLY INVASIVE CARDIAC OUTPUT MONITORING
7 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICES MARKET, BY END-USER
7.1 HOSPITALS
7.1.1 CRITICAL CARE
7.1.2 PERI-OPERATIVE
7.2 AMBULATORY SURGICAL CENTERS
7.3 OTHERS
8 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICES MARKET, BY COUNTRY
8.1 INTRODUCTION
8.2 U.S.: CARDIAC OUTPUT MONITORING DEVICES MARKET
8.3 CANADA: CARDIAC OUTPUT MONITORING DEVICES MARKET
8.4 MEXICO: CARDIAC OUTPUT MONITORING DEVICES MARKET, BY TYPE
9 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICES MARKET, COMPETITIVE LANDSCAPE
9.1 INTRODUCTION
9.2 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICES MARKET: COMPANY SHARE ANALYSIS
9.3 AGREEMENT & ALLIANCE
9.4 PARTNERSHIP
9.5 COLLABORATION
9.6 EXPANSION
9.7 ACQUISITION
9.8 NEW PRODUCT LAUNCH
9.9 OTHERS
10 NON-INVASIVE AND MINIMALLY INVASIVE CARDIAC OUTPUT MONITORING, BY COMPANY
(Overview, Financials, Products & Services, Strategy, and Developments)*
10.1 CHEETAH MEDICAL
10.2 CNSYSTEM MEDIZINTECHNIK AG
10.3 DELTEX MEDICAL GROUP
10.4 EDWARDS LIFESCIENCES
10.5 FINAPRES MEDICAL SYSTEMS B.V.
10.6 ICU MEDICAL
10.7 LIDCO GROUP PLC
10.8 NIHON KOHDEN CORPORATION
10.9 PHILIPS HEALTHCARE (A SUBSIDIARY OF ROYAL PHILIPS ELECTRONICS)
10.10 PULSION MEDICAL SYSTEMS SE
10.11 TENSYS MEDICAL, INC.
10.12 USCOM LTD
10.13 BIOSENSORS INTERNATIONAL
10.14 INTRA SPECIAL CATHETERS GMBH
10.15 B. BRAUN MELSUNGEN AG
10.16 ARGON MEDICAL DEVICES, INC.
*Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company
11 APPENDIX
11.1 CUSTOMIZATION OPTIONS
11.1.1 PRODUCT ANALYSIS
11.2 RELATED REPORTS
LIST OF TABLES
Table 1 GLOBAL CARDIAC MONITORING DEVICES MARKET PEER MARKET SIZE, 2014 (USD MN)
Table 2 NORTH AMERICAN CARDIAC OUTPUT MONITORING DEVICES MARKET: MACROINDICATORS, BY COUNTRY, 2014 (USD MILLION)
Table 3 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICES MARKET, BY TECHNOLOGY, 2013–2020 (USD MN)
Table 4 NORTH AMERICAN CARDIAC OUTPUT MONITORING DEVICES MARKET, MERITS AND DEMERITS, BY TECHNOLOGY
Table 5 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICES MARKET, BY TYPE, 2013-2020 (USD MN)
Table 6 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICES MARKET, BY GEOGRAPHY, 2013-2020 (USD MN)
Table 7 NORTH AMERICA NON-INVASIVE CARDIAC OUTPUT MONITORING DEVICES MARKET, BY GEOGRAPHY, 2013-2020 (USD MN)
Table 8 NORTH AMERICA MINIMALLY INVASIVE CARDIAC OUTPUT MONITORING DEVICES MARKET, BY GEOGRAPHY, 2013-2020 (USD MN)
Table 9 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICE, BY END-USER, 2013 - 2020 (USD MN)
Table 10 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICE, IN HOSPITALS, BY COUNTRY, 2013-2020 (USD MN)
Table 11 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICE, IN AMBULATORY CARE, BY COUNTRY, 2013-2020 (USD MN)
Table 12 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICE, IN OTHER END USERS, BY COUNTRY, 2013-2020 (USD MN)
Table 13 U.S.: CARDIAC OUTPUT MONITORING DEVICES MARKET, BY TYPE, 2013-2020 (USD MN)
Table 14 U.S.: CARDIAC OUTPUT MONITORING DEVICES MARKET, BY END-USER, 2013 - 2020 (USD MN)
Table 15 CANADA: CARDIAC OUTPUT MONITORING DEVICES MARKET, BY TYPE, 2013-2020 (USD MN)
Table 16 CANADA: CARDIAC OUTPUT MONITORING DEVICES MARKET, BY END-USER, 2013 - 2020 (USD MN)
Table 17 MEXICO: CARDIAC OUTPUT MONITORING DEVICES MARKET, BY TYPE, 2013 - 2020 (USD MN)
Table 18 MEXICO: CARDIAC OUTPUT MONITORING DEVICES MARKET, BY END-USER, 2013 - 2020 (USD MN)
Table 19 DELTEX MEDICAL: KEY FINANCIALS, 2012 - 2014 (USD MN)
Table 20 EDWARDS LIFESCIENCES: KEY FINANCIALS, 2010-2014 (USD MN)
Table 21 ICU MEDICAL: KEY FINANCIALS, 2012 - 2014 (USD MN)
Table 22 LIDCO GROUP PLC: KEY FINANCIALS, 2012 - 2014 (USD MN)
Table 23 NIHON KOHDEN CORPORATION: KEY FINANCIALS, 2012 - 2014 (USD MN)
Table 24 PHILIPS: KEY FINANCIALS, 2011 - 2013 (USD MN)
Table 25 PULSION MEDICAL SYSTEMS SE: KEY FINANCIALS, 2011 - 2013 (USD MN)
Table 26 USCOM LTD: KEY FINANCIALS, 2012 - 2014 (USD MN)
Table 27 BIOSENSORS INTERNATIONAL: BUSINESS SEGMENT, 2011-2014 (USD MN)
Table 28 B. BRAUN MELSUNGEN AG: BUSINESS SEGMENT, 2010-2014 (USD MN)
Table 29 B. BRAUN MELSUNGEN AG: GEOGRAPHICAL SEGMENT, 2010-2014 (USD MN)
Table 1 GLOBAL CARDIAC MONITORING DEVICES MARKET PEER MARKET SIZE, 2014 (USD MN)
Table 2 NORTH AMERICAN CARDIAC OUTPUT MONITORING DEVICES MARKET: MACROINDICATORS, BY COUNTRY, 2014 (USD MILLION)
Table 3 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICES MARKET, BY TECHNOLOGY, 2013–2020 (USD MN)
Table 4 NORTH AMERICAN CARDIAC OUTPUT MONITORING DEVICES MARKET, MERITS AND DEMERITS, BY TECHNOLOGY
Table 5 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICES MARKET, BY TYPE, 2013-2020 (USD MN)
Table 6 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICES MARKET, BY GEOGRAPHY, 2013-2020 (USD MN)
Table 7 NORTH AMERICA NON-INVASIVE CARDIAC OUTPUT MONITORING DEVICES MARKET, BY GEOGRAPHY, 2013-2020 (USD MN)
Table 8 NORTH AMERICA MINIMALLY INVASIVE CARDIAC OUTPUT MONITORING DEVICES MARKET, BY GEOGRAPHY, 2013-2020 (USD MN)
Table 9 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICE, BY END-USER, 2013 - 2020 (USD MN)
Table 10 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICE, IN HOSPITALS, BY COUNTRY, 2013-2020 (USD MN)
Table 11 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICE, IN AMBULATORY CARE, BY COUNTRY, 2013-2020 (USD MN)
Table 12 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICE, IN OTHER END USERS, BY COUNTRY, 2013-2020 (USD MN)
Table 13 U.S.: CARDIAC OUTPUT MONITORING DEVICES MARKET, BY TYPE, 2013-2020 (USD MN)
Table 14 U.S.: CARDIAC OUTPUT MONITORING DEVICES MARKET, BY END-USER, 2013 - 2020 (USD MN)
Table 15 CANADA: CARDIAC OUTPUT MONITORING DEVICES MARKET, BY TYPE, 2013-2020 (USD MN)
Table 16 CANADA: CARDIAC OUTPUT MONITORING DEVICES MARKET, BY END-USER, 2013 - 2020 (USD MN)
Table 17 MEXICO: CARDIAC OUTPUT MONITORING DEVICES MARKET, BY TYPE, 2013 - 2020 (USD MN)
Table 18 MEXICO: CARDIAC OUTPUT MONITORING DEVICES MARKET, BY END-USER, 2013 - 2020 (USD MN)
Table 19 DELTEX MEDICAL: KEY FINANCIALS, 2012 - 2014 (USD MN)
Table 20 EDWARDS LIFESCIENCES: KEY FINANCIALS, 2010-2014 (USD MN)
Table 21 ICU MEDICAL: KEY FINANCIALS, 2012 - 2014 (USD MN)
Table 22 LIDCO GROUP PLC: KEY FINANCIALS, 2012 - 2014 (USD MN)
Table 23 NIHON KOHDEN CORPORATION: KEY FINANCIALS, 2012 - 2014 (USD MN)
Table 24 PHILIPS: KEY FINANCIALS, 2011 - 2013 (USD MN)
Table 25 PULSION MEDICAL SYSTEMS SE: KEY FINANCIALS, 2011 - 2013 (USD MN)
Table 26 USCOM LTD: KEY FINANCIALS, 2012 - 2014 (USD MN)
Table 27 BIOSENSORS INTERNATIONAL: BUSINESS SEGMENT, 2011-2014 (USD MN)
Table 28 B. BRAUN MELSUNGEN AG: BUSINESS SEGMENT, 2010-2014 (USD MN)
Table 29 B. BRAUN MELSUNGEN AG: GEOGRAPHICAL SEGMENT, 2010-2014 (USD MN)
LIST OF FIGURES
Figure 1 CARDIAC OUTPUT MONITORING DEVICES MARKET: SEGMENTATION & COVERAGE
Figure 2 CARDIAC OUTPUT MONITORING DEVICES MARKET: INTEGRATED ECOSYSTEM
Figure 3 TOP-DOWN APPROACH
Figure 4 BOTTOM UP
Figure 5 MACROINDICATOR-BASED APPROACH
Figure 6 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICES MARKET SNAPSHOT
Figure 7 PORTER’S FIVE ANALYSIS
Figure 8 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICES MARKET, BY TECHNOLOGY, 2013-2020 (USD MN)
Figure 9 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICES MARKET, BY TYPE, 2013 - 2020 (USD MN)
Figure 10 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICES MARKET, BY GEOGRAPHY, 2013-2020 (USD MN)
Figure 11 NORTH AMERICA NON-INVASIVE CARDIAC OUTPUT MONITORING DEVICES MARKET, BY GEOGRAPHY, 2013 (USD MN)
Figure 12 NORTH AMERICA MINIMALLY INVASIVE CARDIAC OUTPUT MONITORING DEVICES MARKET, BY GEOGRAPHY, 2013-2020 (USD MN)
Figure 13 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICE, BY END-USER, 2013 - 2020 (USD MN)
Figure 14 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICES MARKET, IN HOSPITALS, BY COUNTRY, 2013-2020 (USD MN)
Figure 15 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICES MARKET, IN AMBULATORY CARE, BY COUNTRY, 2013-2020 (USD MN)
Figure 16 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICES MARKET, IN OTHER END USERS, BY COUNTRY, 2013-2020 (USD MN)
Figure 17 U.S.: CARDIAC OUTPUT MONITORING DEVICES MARKET, BY TYPE, 2013-2020 (USD MN)
Figure 18 U.S.: CARDIAC OUTPUT MONITORING DEVICES MARKET, BY END-USER, 2013-2020 (USD MN)
Figure 19 CANADA: CARDIAC OUTPUT MONITORING DEVICES MARKET, BY TYPE, 2013-2020 (USD MN)
Figure 20 CANADA: CARDIAC OUTPUT MONITORING DEVICES MARKET, BY END-USER, 2013-2020(USD MN)
Figure 21 MEXICO: CARDIAC OUTPUT MONITORING DEVICES MARKET, BY TYPE, 2013-2020 (USD MN)
Figure 22 MEXICO: CARDIAC OUTPUT MONITORING DEVICES MARKET, BY END-USER, 2013-2020 (USD MN)
Figure 23 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICES MARKET SHARES, BY COMPANY, 2014 (%)
Figure 24 DELTEX MEDICAL REVENUE MIX, 2014 (%)
Figure 25 EDWARDS LIFESCIENCES REVENUE MIX, 2014 (%)
Figure 26 ICU MEDICAL REVENUE MIX, 2014 (%)
Figure 27 LIDCO GROUP PLC, REVENUE MIX, 2014 (%)
Figure 28 NIHON KOHDEN CORPORATION, REVENUE MIX, 2014 (%)
Figure 29 PHILLIPS: REVENUE MIX 2014 (%)
Figure 30 PULSION MEDICAL SYSTEMS SE: REVENUE MIX 2013 (%)
Figure 31 BIOSENSORS INTERNATIONAL: REVENUE MIX, 2014 (%)
Figure 32 B. BRAUN MELSUNGEN AG: REVENUE MIX, 2014 (%)
Figure 1 CARDIAC OUTPUT MONITORING DEVICES MARKET: SEGMENTATION & COVERAGE
Figure 2 CARDIAC OUTPUT MONITORING DEVICES MARKET: INTEGRATED ECOSYSTEM
Figure 3 TOP-DOWN APPROACH
Figure 4 BOTTOM UP
Figure 5 MACROINDICATOR-BASED APPROACH
Figure 6 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICES MARKET SNAPSHOT
Figure 7 PORTER’S FIVE ANALYSIS
Figure 8 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICES MARKET, BY TECHNOLOGY, 2013-2020 (USD MN)
Figure 9 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICES MARKET, BY TYPE, 2013 - 2020 (USD MN)
Figure 10 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICES MARKET, BY GEOGRAPHY, 2013-2020 (USD MN)
Figure 11 NORTH AMERICA NON-INVASIVE CARDIAC OUTPUT MONITORING DEVICES MARKET, BY GEOGRAPHY, 2013 (USD MN)
Figure 12 NORTH AMERICA MINIMALLY INVASIVE CARDIAC OUTPUT MONITORING DEVICES MARKET, BY GEOGRAPHY, 2013-2020 (USD MN)
Figure 13 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICE, BY END-USER, 2013 - 2020 (USD MN)
Figure 14 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICES MARKET, IN HOSPITALS, BY COUNTRY, 2013-2020 (USD MN)
Figure 15 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICES MARKET, IN AMBULATORY CARE, BY COUNTRY, 2013-2020 (USD MN)
Figure 16 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICES MARKET, IN OTHER END USERS, BY COUNTRY, 2013-2020 (USD MN)
Figure 17 U.S.: CARDIAC OUTPUT MONITORING DEVICES MARKET, BY TYPE, 2013-2020 (USD MN)
Figure 18 U.S.: CARDIAC OUTPUT MONITORING DEVICES MARKET, BY END-USER, 2013-2020 (USD MN)
Figure 19 CANADA: CARDIAC OUTPUT MONITORING DEVICES MARKET, BY TYPE, 2013-2020 (USD MN)
Figure 20 CANADA: CARDIAC OUTPUT MONITORING DEVICES MARKET, BY END-USER, 2013-2020(USD MN)
Figure 21 MEXICO: CARDIAC OUTPUT MONITORING DEVICES MARKET, BY TYPE, 2013-2020 (USD MN)
Figure 22 MEXICO: CARDIAC OUTPUT MONITORING DEVICES MARKET, BY END-USER, 2013-2020 (USD MN)
Figure 23 NORTH AMERICA CARDIAC OUTPUT MONITORING DEVICES MARKET SHARES, BY COMPANY, 2014 (%)
Figure 24 DELTEX MEDICAL REVENUE MIX, 2014 (%)
Figure 25 EDWARDS LIFESCIENCES REVENUE MIX, 2014 (%)
Figure 26 ICU MEDICAL REVENUE MIX, 2014 (%)
Figure 27 LIDCO GROUP PLC, REVENUE MIX, 2014 (%)
Figure 28 NIHON KOHDEN CORPORATION, REVENUE MIX, 2014 (%)
Figure 29 PHILLIPS: REVENUE MIX 2014 (%)
Figure 30 PULSION MEDICAL SYSTEMS SE: REVENUE MIX 2013 (%)
Figure 31 BIOSENSORS INTERNATIONAL: REVENUE MIX, 2014 (%)
Figure 32 B. BRAUN MELSUNGEN AG: REVENUE MIX, 2014 (%)
